Sign in
Taking people in United KingdomNo phase

Scans to study how aortic stenosis worsens over time

Follows people with aortic stenosis using heart scans to learn how it progresses.

Key facts

Who runs it
University of Edinburgh
Where
Edinburgh, United KingdomSee the site
Trial code
Registry title
The Scottish Aortic Stenosis LongiTudinal Imaging and biomarkeR (SALTIRE) Programme
Status
Recruiting
People taking part
300 people, planned
Started
22 May 2023
Expected to end
22 May 2028
Type of study
Observational, 3 groups
Treatments tested
  • PET-CT
Record updated
21 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people over 50 with aortic stenosis (a narrowed heart valve) of any severity, or an aortic valve thickening, or a tissue replacement aortic valve. It also takes healthy volunteers of similar age and sex.

Age
Older than 50 years.
Sex
Men and women can join.
Disease stage
Mild aortic stenosis (peak velocity 2.5-2.9 m/s), moderate (peak velocity 3.0-4.0 m/s) or severe (peak velocity >4.0 m/s; only previously recruited patients). Also aortic sclerosis: a thickened three-leaflet valve that does not block blood flow.
Earlier treatment
People with a bioprosthetic (tissue) aortic valve replacement can join, put in by surgery or through a catheter.

Main reasons for not taking part

  • Allergy to iodinated contrast dye.
  • Poor kidney function (eGFR of <30 mL/min/1.73m2).
  • Pregnant or breastfeeding women.
  • Known rheumatic heart disease, ochronosis or familial homozygous hypercholesterolaemia.
  • Unable or unwilling to give informed consent.

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Male or female aged >50 years
  • Provision of informed consent prior to any study specific procedures
  • Patients with bioprosthetic aortic valve replacements, including both surgically and transcatheter implanted valves
  • Patients with severe aortic stenosis (peak velocity >4.0 m/s; previously recruited patients)
  • Patients with moderate aortic stenosis (peak velocity 3.0-4.0 m/s; new prospectively recruited patients)
  • Patients with mild aortic stenosis (peak velocity 2.5-2.9 m/s; new prospectively recruited patients)
  • Patients with aortic sclerosis (tri-leaflet thickened aortic valve with no obstruction of ventricular outflow)
  • Age and sex-matched healthy volunteers

Who cannot take part

  • Those with an allergy to iodinated contrast
  • Patients with known Rheumatic Heart Disease
  • Patients with impaired renal function (eGFR of <30 mL/min/1.73m2)
  • Inability or unwilling to give informed consent
  • Women who are pregnant or breastfeeding
  • Patients with known Ochronosis
  • Patients with known Familial Homozygous Hypercholesterolaemia

Where in United Kingdom

  • University of EdinburghEdinburgh, United KingdomContact: Neil CraigTaking people

About the trial

What the trial wants to find out

The goal of this observational study is to understand the processes of what causes and accelerates the disease progress in aortic stenosis and following aortic valve replacement.

Read full original descriptionShow less

Participants will undergo transthoracic echocardiography every 6 months, with annual visits for state-of-the-art scanning techniques including positron-emission tomography combined with computed tomography or magnetic resonance imaging with radiotracers designed to look at disease processes including fibrosis, calcification, inflammation and thrombosis activity.

The 3 groups in the trial

  • Aortic Stenosis

    Participants with Aortic Stenosis across the spectrum of disease severity

    Treatment: PET-CT

  • Aortic Valve Replacement

    Participants who have previously undergone aortic valve replacement

    Treatment: PET-CT

  • Healthy Volunteers

    Healthy Volunteers for the purposes of case-control analysis

    Treatment: PET-CT

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
The Scottish Aortic Stenosis LongiTudinal Imaging and biomarkeR (SALTIRE) Programme
Plain-language title
Scans to study how aortic stenosis worsens over timeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
21 September 2026